Digital Delivery of Information About Genetic Testing for Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

1,140

Participants

Timeline

Start Date

July 5, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

January 16, 2023

Conditions
Breast Neoplasm Female
Interventions
OTHER

Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform

"Participants will receive a link to the digital pre-test information. This will consist of text covering: Genetics and cancer risk; Genetics testing; What will happen if your test is positive; What will happen if your test is negative; Implications for insurance.~Where relevant, parts of the text will be linked through to additional information, such as insurance advice from the Association of British Insurers. Participants will be able to call a genetic counsellor on the hotline during weekday office hours, should they have any questions or require further information."

OTHER

Digital Delivery of Genetic Test Results via the BRCA-DIRECT Platform

Participants will receive a digital message that their results are available. When they click this, they will receive digital notification of their negative (normal) result in short form. Full details will be provided in an individualised letter.

Trial Locations (5)

M23 9LT

Wythenshawe Hospital, Manchester

SW3 6JJ

Royal Marsden Hospital, Chelsea, Chelsea

KT2 7QB

Royal Marsden Hospital, Kingston, Kingston

SM2 5PT

Royal Marsden Hospital, Sutton, Sutton

M8 5RB

North Manchester General Hospital, Manchester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Sussex

OTHER

collaborator

University of Manchester

OTHER

collaborator

Cancer Research UK

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER